-
公开(公告)号：US08199326B2
公开(公告)日：2012-06-12
申请号：US12689525
申请日：2010-01-19
申请人： Peter Dreyer , Günter Steinert , Alfred Kelm , Christian Jäger , Livio Fornasiero , Hartmut Stark , Ralf Buchtal , Burkhard Stock , Ralf Döring , Anja Künzel, legal representative
发明人： Peter Dreyer , Günter Steinert , Alfred Kelm , Christian Jäger , Livio Fornasiero , Hartmut Stark , Ralf Buchtal , Burkhard Stock , Ralf Döring
CPC分类号： G01N21/3504 , G01N2021/3133 , G01N2201/069
摘要： A gas concentration-measuring device makes it possible to measure gas components in a gas sample. An interferometer, based on a dual-band Fabry-Perot interferometer (1), is provided with a transmission spectrum that can be set by a control voltage (38). The control voltage (38) of the dual-band Fabry-Perot interferometer (1) is synchronized over the course of time with the activation and deactivation of the radiation sources (11, 12).
摘要翻译： 气体浓度测量装置可以测量气体样品中的气体成分。 基于双频带法布里 - 珀罗干涉仪（1）的干涉仪被提供有可由控制电压（38）设定的透射光谱。 双波段法布里 - 珀罗干涉仪（1）的控制电压（38）随着辐射源（11,12）的激活和去激活而在时间上同步。
-
公开(公告)号：US08182832B2
公开(公告)日：2012-05-22
申请号：US12424353
申请日：2009-04-15
IPC分类号： A61F2/28
摘要： The present invention relates to an X-ray amorphous-crystalline material with high solubility which can be used as a bioactive bone replacement material and as a substrate material in biotechnology. The new material comprising crystalline and X-ray amorphous phases is characterized in that according to 31P-NMR measurements, it contains Q0-groups of orthophosphate and Q1-groups of diphosphate, the orthophosphates or Q0-groups making up 70 to 99.9% by weight relative to the total phosphorus content of the finished material and the diphosphates or Q1-groups making up 0.1 to 30% by weight relative to the total phosphorus content of the finished material, and that according to X-ray diffractometric measurements and relative to the total weight of the finished material, 30 to 99.9% by weight of a main crystal phase consisting of Ca2K1−xNa1+x(PO4)2, where x=0.1 to 0.9, is contained in the bone replacement material and 0.1 to 20% by weight of a substance selected from the group consisting of Na2CaP2O7, K2CaP2O7, Ca2P2O7 and mixtures thereof is contained as a secondary crystal phase, the X-ray amorphous phases contained besides the main crystal phase jointly making up 0.1 to 70% by weight relative to the total weight of the finished material.
摘要翻译： 本发明涉及可用作生物活性骨置换材料和作为生物技术中的底物材料的具有高溶解度的X射线非晶态材料。 包含结晶和X射线无定形相的新材料的特征在于根据31P-NMR测量，其包含正磷酸盐和Q1-二磷酸盐基团的Q0-组，正磷酸盐或Q0-基团组成70-99.9重量％ 相对于成品材料的总磷含量和相对于成品材料的总磷含量为0.1〜30重量％的二磷酸盐或Q1-基团的总磷含量，并且根据X射线衍射测量值和相对于总量 在骨替代材料中含有30〜99.9重量％的由Ca2K1-xNa1 + x（PO4）2构成的主晶相，x = 0.1〜0.9，0.1〜20重量％ 含有选自Na 2 CO 3 P 2 O 7，K 2 Ca 2 O 7，Ca 2 P 2 O 7的物质及其混合物作为二级结晶相，除了主晶相外含有的X射线非晶相共重量为0.1-70％ t相对于成品材料的总重量。
-
公开(公告)号：US06345812B1
公开(公告)日：2002-02-12
申请号：US09535480
申请日：2000-03-24
IPC分类号： B01F304
CPC分类号： C02F3/201 , B01F3/04269 , B01F2003/04276 , B01F2003/04297 , B01F2215/0052 , Y02W10/15
摘要： A plate-like water aerator is provided. A plate, made of elastomeric material, is disposed on a rigid, essentially planar mounting support and covers the one or more air supply connections thereof. The plate is provided with fine slits for the discharge of air. The mounting support has a circumferential rim that is angled-off at substantially right angles. The mounting support also has a circumferential rib that extends parallel to the rim in such a way as to form a circumferential groove between the rib and the rim. The plate has an essentially u-shaped rim portion, a radially inwardly disposed leg of which surrounds the rim of the mounting support and engages in the circumferential groove in a manner free of play.
摘要翻译： 提供了一种板状水曝气器。 由弹性体材料制成的板被设置在刚性的基本上平面的安装支撑件上并且覆盖其一个或多个空气供应连接。 该板设有用于排出空气的细缝。 安装支撑件具有以大致直角成角度的圆周边缘。 安装支架还具有平行于边缘延伸的圆周肋，以便在肋和轮辋之间形成圆周槽。 板具有基本上为U形的边缘部分，径向向内设置的腿围绕安装支撑件的边缘并且以没有游隙的方式接合在周向凹槽中。
-
4.发明授权公开(公告)号：US07547448B2
公开(公告)日：2009-06-16
申请号：US10689219
申请日：2003-10-20
IPC分类号： A61F2/28
摘要： The present invention relates to an X-ray amorphous-crystalline material with high solubility which can be used as a bioactive bone replacement material and as a substrate material in biotechnology. The new material comprising crystalline and X-ray amorphous phases is characterized in that according to 31P-NMR measurements, it contains Q0-groups of orthophosphate and Q1-groups of diphosphate, the ortho-phosphates or Q0-groups making up 70 to 99.9% by weight relative to the total phosphorus content of the finished material and the diphosphates or Q1-groups making up 0.1 to 30% by weight relative to the total phosphorus content of the finished material, and that according to X-ray diffractometric measurements and relative to the total weight of the finished material, 30 to 99.9% by weight of a main crystal phase consisting of Ca2K1−xNa1+x(PO4)2, where x=0.1 to 0.9, is contained in the bone replacement material and 0.1 to 20% by weight of a substance selected from the group consisting of Na2CaP2O7, K2CaP2O7, Ca2P2O7 and mixtures thereof is contained as a secondary crystal phase, the X-ray amorphous phases contained besides the main crystal phase jointly making up 0.1 to 70% by weight relative to the total weight of the finished material.
摘要翻译： 本发明涉及可用作生物活性骨置换材料和作为生物技术中的底物材料的具有高溶解度的X射线非晶态材料。 包括结晶和X射线非晶相的新材料的特征在于，根据31P-NMR测量，其包含正磷酸盐和Q 1组二磷酸酯的QO-基团，正磷酸盐或QO-基团占70-99.9％ 相对于成品材料的总磷含量和相对于成品材料的总磷含量为0.1〜30重量％的二磷酸盐或Q1-基团的总磷含量，根据X射线衍射测定，相对于 成骨材料的总重量为30〜99.9重量％的由Ca2K1-xNa1 + x（PO4）2组成的主晶相，其中x = 0.1〜0.9，包含在骨置换材料中，0.1〜20重量％ 含有选自Na 2 CO 3 O 2 O 7，K 2 Ca 2 O 7，Ca 2 P 2 O 7的物质及其混合物作为二级结晶相，主晶相以外的X射线非晶相共同构成0.1〜70重量％ 相对于成品材料的总重量。
-
公开(公告)号：US07223420B2
公开(公告)日：2007-05-29
申请号：US10689221
申请日：2003-10-20
申请人： Georg Berger , Heidi Marx , Christian Jäger , Jutta Pauli
发明人： Georg Berger , Heidi Marx , Christian Jäger , Jutta Pauli
IPC分类号： A61L24/00 , A61K9/14 , A61K33/42 , A61K33/08 , A61K33/00 , A01N59/26 , A01N59/06 , A01N59/00
CPC分类号： A61L24/001 , A61L27/56 , A61L2430/02
摘要： The present invention relates to a powder mixture for resorbable calcium phosphate biocements, which mixture consists of 40–99% by volume of powder having a particle size of 0.1–10 μm, 1–20% by volume of powder having a particle size of 10–43 μm and 0–59% by volume of powder having a particle size of 43–315 μm, which powder is obtained by grinding the spontaneously crystallizing melts of a material comprising crystalline and X-ray amorphous phases, which material a) according to 31P-NMR measurements, contains Q0-groups of orthophosphate and Q1-groups of diphosphate, the orthophosphates or Q0-groups making up 65 to 99.9% by weight relative to the total phosphorus content of the powder mixture and the diphosphates or Q1-groups making up 0.1 to 35% by weight relative to the total phosphorus content of the powder mixture, and b) according to X-ray diffractometric measurements and relative to the total weight of the powder mixture, contains 35 to 99.9% by weight of a main crystal phase consisting of various Ca-orthophosphates and 0.1 to 20% by weight of a secondary crystal phase consisting of various Ca-diphosphates and chain phosphates, and c) besides the main crystal phase, contains an X-ray amorphous phase which in total makes up 0.1 to 65% by weight relative to the total weight of the powder mixture.
摘要翻译： 本发明涉及可再吸收的磷酸钙生物聚合物的粉末混合物，该混合物由40-99体积％的粒径为0.1-10μm的粉末，1-20体积％的粒径为10的粉末组成 -43μm和0-59体积％的粉末，其粒径为43-315μm，粉末通过研磨包含结晶和X射线非晶相的材料的自发结晶熔体获得，该材料a）根据 P-NMR测量包含正磷酸盐，正磷酸盐或正好磷酸盐的正二磷酸盐和Q 1 - 亚基的Q 0 - 相对于粉末混合物的总磷含量为65至99.9重量％，相对于该粉末混合物的二磷酸盐或Q 1个亚组为0.1至35重量％ 粉末混合物的总磷含量，和b）根据X射线衍射测量和相对于粉末混合物的总重量，c 包含35〜99.9重量％的由各种正磷酸钙组成的主晶相和0.1〜20重量％的由各种Ca-二磷酸酯和链磷酸酯组成的二次相晶相，以及c）除了主晶相外，还含有 X射线非晶相，相对于粉末混合物的总重量，其总重量为0.1〜65重量％。
-
公开(公告)号：US07459170B2
公开(公告)日：2008-12-02
申请号：US10689217
申请日：2003-10-20
IPC分类号： A61F2/28
CPC分类号： C03C3/078 , A61F2/28 , A61F2002/30968 , A61F2310/00293 , A61F2310/00329 , A61L27/10 , A61L27/12 , A61L27/425 , A61L27/50 , A61L2430/02 , C01B25/45 , C03C3/097 , C03C4/0007 , C03C11/00 , C03C12/00 , C03C14/00 , C04B35/447 , C04B35/653 , C04B2235/3201 , C04B2235/3206 , C04B2235/3208 , C04B2235/3418 , C04B2235/36 , C04B2235/80
摘要： The present invention relates to a material with orthophosphate and having a high solubility which can be used as a bioactive bone replacement material and as a substrate material in biotechnology. According to 31P-NMR measurements, the new material comprises Q0-groups of orthophosphate and Q1-groups of diphosphate, the orthophosphates or Q0-groups making up 65 to 99.9% by weight relative to the total phosphorus content of the finished material and the diphosphates or Q1-groups making up 0.1 to 35% by weight relative to the total phosphorus content of the finished material, and wherein according to X-ray diffractometric measurements and relative to the total weight of the finished material, 35 to 99.9% by weight of a main crystal phase consisting of Ca10Na(PO4)7, Ca10K(PO4)7, mixtures thereof or mixed crystals according to the general formula Ca10KxNa1−x(PO4)7, where x=0 to 1, is contained in the bone replacement material and 0.1 to 25% by weight of a substance selected from the group consisting of Na2CaP2O7, K2CaP2O7, Ca2P2O7 and mixtures thereof is contained as a secondary crystal phase, and the X-ray amorphous phases contained besides the main crystal phase jointly make up 0.1 to 65% by weight.
摘要翻译： 本发明涉及具有正磷酸盐并具有高溶解性的材料，其可用作生物活性骨置换材料和生物技术中的底物材料。 根据31P-NMR测量，新材料包含正磷酸盐和Q 1组二磷酸盐的Q0-基团，相对于成品材料和二磷酸盐的总磷含量，正磷酸盐或QO-基团占重量的65-99.9％ 或Q1组相对于成品材料的总磷含量为0.1〜35重量％，并且其中根据X射线衍射测量值和相对于成品材料的总重量，35至99.9重量％ 骨替代材料中含有由Ca10Na（PO4）7，Ca10K（PO4）7，其混合物或根据通式Ca10KxNa1-x（PO4）7的混合物构成的主晶相，其中x = 0至1） 含有0.1〜25重量％的选自Na 2 CO 3 P 2 O 7，K 2 Ca 2 O 7，Ca 2 P 2 O 7及其混合物的物质作为二次结晶相，除了主晶相以外含有的X射线非晶相共同构成0.1 至65重量％。
-
-
-
-
-
搜索结果
6 条记录 (耗时 0.033 秒)
